By the same authors

From the same journal

From the same journal

The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence

Research output: Contribution to journalArticle

Standard

The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis : A Critique of the Evidence. / Sideris, Eleftherios; Corbett, Mark Stephen; Palmer, Stephen John; Woolacott, Nerys Frances; Bojke, Laura.

In: Pharmacoeconomics., Vol. 34, No. 11, 08.06.2016, p. 1101–1110.

Research output: Contribution to journalArticle

Harvard

Sideris, E, Corbett, MS, Palmer, SJ, Woolacott, NF & Bojke, L 2016, 'The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence', Pharmacoeconomics., vol. 34, no. 11, pp. 1101–1110. https://doi.org/10.1007/s40273-016-0419-7

APA

Sideris, E., Corbett, M. S., Palmer, S. J., Woolacott, N. F., & Bojke, L. (2016). The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence. Pharmacoeconomics., 34(11), 1101–1110. https://doi.org/10.1007/s40273-016-0419-7

Vancouver

Sideris E, Corbett MS, Palmer SJ, Woolacott NF, Bojke L. The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence. Pharmacoeconomics. 2016 Jun 8;34(11):1101–1110. https://doi.org/10.1007/s40273-016-0419-7

Author

Sideris, Eleftherios ; Corbett, Mark Stephen ; Palmer, Stephen John ; Woolacott, Nerys Frances ; Bojke, Laura. / The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis : A Critique of the Evidence. In: Pharmacoeconomics. 2016 ; Vol. 34, No. 11. pp. 1101–1110.

Bibtex - Download

@article{68885c682cda49fd8397985d8474e13a,
title = "The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence",
author = "Eleftherios Sideris and Corbett, {Mark Stephen} and Palmer, {Stephen John} and Woolacott, {Nerys Frances} and Laura Bojke",
note = "{\circledC} Springer International Publishing Switzerland 2016. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.",
year = "2016",
month = "6",
day = "8",
doi = "10.1007/s40273-016-0419-7",
language = "English",
volume = "34",
pages = "1101–1110",
journal = "Pharmacoeconomics.",
number = "11",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis

T2 - Pharmacoeconomics.

AU - Sideris, Eleftherios

AU - Corbett, Mark Stephen

AU - Palmer, Stephen John

AU - Woolacott, Nerys Frances

AU - Bojke, Laura

N1 - © Springer International Publishing Switzerland 2016. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.

PY - 2016/6/8

Y1 - 2016/6/8

U2 - 10.1007/s40273-016-0419-7

DO - 10.1007/s40273-016-0419-7

M3 - Article

VL - 34

SP - 1101

EP - 1110

JO - Pharmacoeconomics.

JF - Pharmacoeconomics.

IS - 11

ER -